Seeking Alpha

ViroPharma (VPHM): Q2 EPS of $0.20 beats by $0.02. Revenue of $82M (+25%) vs. $75M. Shares...

ViroPharma (VPHM): Q2 EPS of $0.20 beats by $0.02. Revenue of $82M (+25%) vs. $75M. Shares +21.7% premarket. (PR)
Comments (2)
  • An obvious buy before earnings based on applied technical analysis and recent momentum in biotech sector
    29 Jul 2009, 09:19 AM Reply Like
  • beware any "ANALysis" that claims something is "an obvious buy"
    9 Nov 2009, 04:22 PM Reply Like
DJIA (DIA) S&P 500 (SPY)